on LUCIBEL (EPA:ALUCI)
Michèle Pelletier Aouizérate honored at the Health and Medical Aesthetics Awards
On December 14, 2024, Michèle Pelletier Aouizérate received the Research and Innovation Prize at the Health and Medical Aesthetics Awards in Paris. A dermatologist specializing in photobiomodulation, her research over the past 20 years has had a significant impact, particularly in the treatment of respiratory problems linked to COVID-19.
The event, which brought together more than 700 participants, rewarded her commitment with a pioneering publication in 2021. Founder of the European LED Academy, she has promoted the international development of this technology in dermatology.
Lucibel, which benefits from his expertise, continues to rely on his innovations, particularly in the OVE range. Frédéric Granotier, President of Lucibel, praised his contribution to the company's strategy in photobiomodulation.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all LUCIBEL news